Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$112.16 -1.79 (-1.57%)
At close: Nov 11, 2026 · 4:00 PM EST

Rhythm Pharmaceuticals (RYTM) Return on Assets [ROA] (2017 - 2026)

Updated

Rhythm Pharmaceuticals (RYTM) posted Return on Assets [ROA] of -44.03% for Q3 2026, down 0.29 percentage points from -43.73% a year earlier but up 2.66 percentage points from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Return on Assets [ROA] (2017 - 2026) Analysis & Trends

For FY2025, Rhythm Pharmaceuticals' Return on Assets [ROA] came in at -45.05%, up 26.83 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of +9.02 percentage points (FY2020 to FY2025).
  • In prior years, Rhythm Pharmaceuticals' Return on Assets [ROA] was -71.89% in FY2024 (-20.25 pp), -51.64% in FY2023 (-0.77 pp), -50.88% in FY2022 (-23.93 pp) and -26.95% in FY2021 (+27.12 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -92.62% in Q1 2024 to a high of -20.31% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Assets [ROA] increased in five of the last eight quarters, with an average year-over-year change of +15.30 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2025, with a gain of 49.30 percentage points; the weakest was Q2 2022, with a drop of 57.82 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -46.69% (Q2 2026), -43.94% (Q1 2026) and -39.83% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Rhythm Pharmaceuticals 7.90 Bn 6.52 Bn 79.96 Mn -44.52%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -44.52%
Jun 30, 2026 -47.00%
Mar 31, 2026 -44.71%
Dec 31, 2025 -41.07%
Sep 30, 2025 -45.03%
Jun 30, 2025 -50.05%
Mar 31, 2025 -44.64%
Dec 31, 2024 -70.04%
Sep 30, 2024 -70.30%
Jun 30, 2024 -81.60%
Mar 31, 2024 -92.68%
Dec 31, 2023 -53.70%
Sep 30, 2023 -55.80%
Jun 30, 2023 -55.32%
Mar 31, 2023 -49.42%
Dec 31, 2022 -46.94%
Sep 30, 2022 -54.47%
Jun 30, 2022 -62.77%
Mar 31, 2022 -54.23%
Dec 31, 2021 -20.29%
API Access

Rhythm Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RYTM&period=max&api_key=YOUR_API_KEY